Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience
Conclusion
Although data are limited and all known exposures have occurred in the first trimester, no increased risk of fetal abnormalities or adverse pregnancy outcomes associated with gestational exposure to DMF has been observed.
Funding
Biogen, Inc.
Source: Neurology and Therapy - Category: Neurology Source Type: research
More News: Arthritis | Brain | Clinical Trials | Gastroenterology | Miscarriage | Multiple Sclerosis | Neurology | Pregnancy | Psoriasis | Reproduction Medicine | Rheumatoid Arthritis | Rheumatology | Study | Toxicology | Women